Simon Rushbrook

6.3k citations
46 papers · 2.2k indexed · 1 hit paper · h-index 24

Impact in

  • Hepatology top 0.5%
    • Liver Diseases and Immunity
    • Hepatitis C virus research
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

    • Liver Diseases and Immunity 16
    • Hepatitis C virus research 8
    • Liver Disease Diagnosis and Treatment 18
    • Hepatitis B Virus Studies 6

Simon Rushbrook

44 papers receiving 2.2k citations

Hit Papers

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis 2019 · 205 citations
205201920262021202350100150200

Peers

Simon Rushbrook
Comparison fields: 5 of 91
  • Hepatology 1.0k
  • Immunology 534
  • Epidemiology 850
  • Oncology 627
  • Surgery 617
Replace Evaggelia Liaskou with:
Evaggelia Liaskou United Kingdom
Stuart M. Curbishley United Kingdom
Weici Zhang United States
Fusao Ikeda Japan
Carlo Fabris Italy
Éric Nguyen-Khac France
Imad Nasser United States
Masahiko Sugitani Japan
Kiyoaki Ito Japan
V. Desmet Belgium
Simon Rushbrook relative to Evaggelia Liaskou United Kingdom Evaggelia Liaskou's profile →
Citations per field
00.5×
Evaggelia Liaskou · 1×
Citations per year

Countries citing papers authored by Simon Rushbrook

Since Specialization
Citations

This map shows the geographic impact of Simon Rushbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rushbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rushbrook more than expected).

Fields of papers citing papers by Simon Rushbrook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Rushbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rushbrook. The network helps show where Simon Rushbrook may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Rushbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Rushbrook Line = papers co-authored together Simon Rushbrook links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20245
4 202333
5 20228
6 20211
7 202121
8 2020142
9
The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.
20193
10 201418
11 201235
12 201218
13 20081
14 200722
15 2005233
16 200523
17 200442
18 20044
19 200377
20 200329

About Simon Rushbrook

Simon Rushbrook is a scholar working on Hepatology, Epidemiology, Critical Care and Intensive Care Medicine, Gastroenterology and Surgery, having authored 46 papers that have together received 2.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Liver Diseases and Immunity (16 papers), Hepatitis C virus research (8 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers), Hepatitis B Virus Studies (6 papers), Immune Cell Function and Interaction (5 papers), Inflammatory Bowel Disease (5 papers) and Gallbladder and Bile Duct Disorders (4 papers). The work is most often cited by research in Hepatology (1.0k citations), Immunology (534 citations), Epidemiology (850 citations), Oncology (627 citations) and Surgery (617 citations). Simon Rushbrook has collaborated with scholars based in United Kingdom, Canada and Italy. Frequent co-authors include Nicholas Coleman, Sarah L. Vowler, Lesley S. Morris, Esther Unitt, Graeme Alexander, Aileen Marshall, Graeme Alexander, Nathan Davies, Ian Scott and William Gelson. Their work appears in journals such as Hepatology, Gut, Gastroenterology, British Journal of Cancer and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026